This Study Consists of Two Study Parts Conducted Under a Single IRB. Part I: Short Term ApoE-dependent Cerebral Blood Flow Response to Sirolimus in Cognitively Normal Adults Part II: Short Term ApoE-dependent Cerebral Blood Flow and Lung Perfusion Response to Sirolimus in Cognitively Normal Adults

NCT05386914 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

205

Enrollment

OTHER

Sponsor class

Conditions

Genetic Predisposition to Disease
Healthy Volunteers

Interventions

DRUG: Sirolimus

Sponsor

University of Missouri-Columbia